These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
14. IPO floodgates unlikely to open after Ark floatation. Louët S Nat Biotechnol; 2004 Apr; 22(4):367-8. PubMed ID: 15060538 [No Abstract] [Full Text] [Related]
15. Biotechnology financing dilemmas and the role of special purpose entities. Schiff L; Murray F Nat Biotechnol; 2004 Mar; 22(3):271-7. PubMed ID: 14990945 [No Abstract] [Full Text] [Related]
16. Life support for life science innovation? Nat Biotechnol; 2007 Feb; 25(2):144. PubMed ID: 17287731 [TBL] [Abstract][Full Text] [Related]
17. Biotech finance: a family affair. Hurwitz EM Nat Biotechnol; 1999 Feb; 17 Suppl():BE35-7. PubMed ID: 10052326 [No Abstract] [Full Text] [Related]
20. The rise of venture capital and biotechnology in the US and Europe. Lee DP; Dibner MD Nat Biotechnol; 2005 Jun; 23(6):672-6. PubMed ID: 15940233 [No Abstract] [Full Text] [Related] [Next] [New Search]